◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › T › TEVA

Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

NYSE · DATA UPDATED 2026-09-11

Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA) operates in the NYSE industry and is headquartered in Tel Aviv-Yafo, Israel with about 31,173 employees. Its market capitalization is roughly $46 billion. In the fiscal year ended 2025-12-31, TEVA reported $17.3B in revenue and $1.4B in net income.

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.

Interactive charts & full statements → Open the TEVA valuation workbench →

TEVA Revenue & Earnings History — Annual Income Statement

Income statement	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Revenue	$17.3B	$17.3B	$16.5B	$15.8B	$14.9B	$15.9B	$16.7B	$16.9B	$18.9B	$22.4B	$21.9B	$19.7B	$20.3B	$20.3B	$20.3B	$18.3B	$16.1B	$13.9B	$11.1B	$9.4B	$8.4B
Gross Profit	$9.1B	$8.9B	$8.1B	$7.6B	$7.0B	$7.6B	$7.7B	$7.5B	$8.3B	$10.8B	$11.9B	$11.4B	$11.1B	$10.7B	$10.7B	$9.5B	$9.1B	$7.4B	$6.0B	$4.9B	$4.3B
Gross Margin %	52.5%	51.8%	48.7%	48.2%	46.7%	47.8%	46.4%	44.6%	44.0%	48.4%	54.1%	57.8%	54.5%	52.7%	52.4%	52.0%	56.2%	53.0%	53.8%	51.8%	50.6%
Operating Income (EBIT)	$2.0B	$2.2B	($303M)	$433M	($2.2B)	$1.7B	($3.6B)	($443M)	($1.6B)	($17.5B)	$2.2B	$3.4B	$4.0B	$1.6B	$2.2B	$3.1B	$3.9B	$2.4B	$1.1B	$2.4B	$801M
Operating Margin %	11.5%	12.5%	-1.8%	2.7%	-14.7%	10.8%	-21.4%	-2.6%	-8.7%	-78.1%	9.8%	17.1%	19.5%	8.1%	10.8%	17.0%	24.0%	17.3%	10.3%	25.5%	9.5%
Net Income	$706M	$1.4B	($1.6B)	($559M)	($2.4B)	$417M	($4.0B)	($999M)	($2.1B)	($16.3B)	$329M	$1.6B	$3.1B	$1.3B	$2.0B	$2.8B	$3.3B	$2.0B	$635M	$2.0B	$546M
Net Margin %	4.1%	8.2%	-9.9%	-3.5%	-16.4%	2.6%	-23.9%	-5.9%	-11.4%	-72.7%	1.5%	8.1%	15.1%	6.2%	9.7%	15.1%	20.7%	14.4%	5.7%	20.8%	6.5%
EBITDA	$2.6B	$3.1B	$4.4B	$433M	($925M)	$4.4B	$4.6B	$4.4B	$186M	($15.5B)	$2.9B	$6.3B	$6.0B	$3.2B	$3.9B	$4.3B	$4.8B	$2.4B	$1.6B	$2.4B	$2.5B
Earnings Per Share (EPS)	$0.61	$1.20	$-1.45	$-0.50	$-2.20	$0.38	$-3.64	$-0.92	$-2.11	$-16.01	$0.34	$1.84	$3.56	$1.49	$2.25	$3.09	$3.62	$2.23	$0.77	$2.35	$0.68
Shares Outstanding (M)	1,181M	1,173M	1,131M	1,119M	1,110M	1,107M	1,095M	1,091M	1,021M	1,016M	961M	864M	858M	850M	873M	893M	921M	896M	820M	830M	805M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

TEVA Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Total Revenue	$4.1B	$4.0B	$4.7B	$4.5B	$4.2B	$3.9B	$4.2B	$4.3B
Gross Profit	$2.2B	$2.0B	$2.7B	$2.3B	$2.1B	$1.9B	$2.1B	$2.1B
Gross Margin %	52.0%	49.5%	56.4%	51.4%	50.3%	48.2%	50.1%	49.6%
Operating Income (EBIT)	$149M	$652M	$300M	$882M	$455M	$519M	($29M)	($51M)
Operating Margin %	3.6%	16.4%	6.4%	19.7%	10.9%	13.3%	-0.7%	-1.2%
Net Income	($576M)	$369M	$480M	$433M	$282M	$214M	($217M)	($437M)
Net Margin %	-13.9%	9.3%	10.2%	9.7%	6.8%	5.5%	-5.1%	-10.1%
EBITDA	($19M)	$877M	$632M	$1.1B	$657M	$953M	$1.2B	$207M
Earnings Per Share (EPS)	$-0.49	$0.31	$0.41	$0.37	$0.24	$0.18	$-0.19	$-0.39
Shares Outstanding (M)	1,181M	1,179M	1,173M	1,164M	1,161M	1,159M	1,133M	1,133M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

TEVA Free Cash Flow History

Cash flow	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Cash from Operations (CFO)	$1.9B	$1.6B	$1.2B	$1.4B	$1.6B	$798M	$1.2B	$538M	$2.4B	$3.5B	$5.2B	$5.5B	$5.1B	$3.2B	$4.6B	$4.1B	$4.1B	$3.4B	$3.2B	$1.8B	$2.1B
Capital Expenditures (CapEx)	$550M	$501M	$498M	$526M	$548M	$562M	$578M	$119M	$651M	$874M	$901M	$772M	$929M	$1.0B	$1.1B	$1.1B	$710M	$719M	$681M	$542M	$390M
Free Cash Flow (FCF)	$1.3B	$1.1B	$749M	$842M	$1.0B	$236M	$638M	$419M	$1.8B	$2.6B	$4.3B	$4.8B	$4.2B	$2.2B	$3.5B	$3.1B	$3.4B	$2.7B	$2.5B	$1.3B	$1.7B
FCF Margin %	7.8%	6.7%	4.5%	5.3%	7.0%	1.5%	3.8%	2.5%	9.5%	11.8%	19.7%	24.3%	20.7%	10.9%	17.1%	16.8%	21.2%	19.1%	23.0%	13.5%	19.8%
Dividends Paid	—	—	—	—	—	—	—	$52M	$22M	$1.2B	$1.6B	$1.2B	$1.2B	$1.1B	$855M	$800M	$668M	$528M	$388M	$299M	$229M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

TEVA Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Cash from Operations (CFO)	$411M	($40M)	$1.2B	$369M	$227M	($105M)	$575M	$693M
Capital Expenditures (CapEx)	$104M	$168M	$142M	$136M	$96M	$127M	$129M	$148M
Free Cash Flow (FCF)	$307M	($208M)	$1.0B	$233M	$131M	($232M)	$446M	$545M
FCF Margin %	7.4%	-5.2%	21.6%	5.2%	3.1%	-6.0%	10.5%	12.6%

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

TEVA Balance Sheet History

Balance sheet	2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Assets	$39.9B	$40.7B	$39.3B	$43.5B	$44.0B	$47.7B	$50.6B	$57.5B	$60.7B	$70.6B	$92.9B	$54.3B	$46.4B	$47.5B	$50.6B	$50.1B	$39.1B	$33.8B	$32.9B	$23.4B	$20.5B
Cash & Cash Equivalents	$3.7B	$3.6B	$3.3B	$3.2B	$2.8B	$2.2B	$2.2B	$2.0B	$1.8B	$963M	$988M	$6.9B	$2.2B	$1.0B	$2.9B	$1.1B	$1.2B	$2.0B	$1.9B	$1.5B	$1.3B
Total Liabilities	$32.1B	$32.8B	$33.6B	$35.4B	$35.4B	$36.4B	$39.6B	$42.4B	$44.9B	$51.9B	$57.9B	$24.3B	$23.1B	$24.9B	$27.7B	$27.8B	$17.1B	$14.6B	$16.5B	$9.7B	$9.3B
Total Debt (Short + Long-Term)	$16.6B	$16.8B	$17.8B	$19.8B	$21.2B	$23.0B	$25.9B	$26.9B	$28.9B	$32.5B	$35.8B	$9.9B	$10.3B	$12.2B	$14.7B	$14.5B	$5.5B	$5.6B	$8.4B	$5.2B	$5.3B
Total Shareholders' Equity	$7.8B	$7.9B	$5.4B	$7.5B	$7.8B	$10.3B	$10.0B	$14.0B	$14.7B	$17.4B	$33.3B	$29.8B	$23.3B	$22.6B	$22.8B	$22.2B	$21.9B	$19.2B	$16.3B	$13.7B	$11.1B

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive TEVA viewer.

Other Companies in Software & IT Services

UL · Unilever PLC American Depositary Shares (each representing One Ordinary Share) — $129 billion
PDD · PDD Holdings Inc. - American Depositary Shares — $111 billion
NWG · NatWest Group plc American Depositary Shares, (each representing two (2) Ordinary Shares) — $69 billion
VALE · VALE S.A. American Depositary Shares Each Representing one common share — $60 billion
HLN · Haleon plc American Depositary Shares (Each representing two Ordinary Shares) — $39 billion
GFI · Gold Fields Limited American Depositary Shares — $32 billion
AVN · Avanceon Limited — Rs 29 billion
SMT · Scottish Mortgage Ord — £17 billion

This page in other languages: עברית

← TEUP All “T” companies TEX →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.